![]() |
|
Michael Stürzl1; Andreas Konrad1; Khaled R. Alkharsah2; Ramona Jochmann1; Mathias Thurau1; Gaby Marquardt1; Thomas F. Schulz2
1Division of Molecular and Experimental Surgery, Department of Surgery, University of Erlangen-Nuremberg, Erlangen, Germany; 2Department of Virology, Medical School Hannover, Hannover, Germany
Kaposi’s sarcoma-associated herpesvirus (KSHV) / human herpesvirus- 8 is the causative agent of the endothelial cell-derived tumour Kaposi’s sarcoma. Herpesviruses possess large complex genomes which provide many options to regulate cellular physiology during the viral life cycle and in the course of tumourigenicity. Novel techniques of systems biology and reverse genetics are increasingly applied to dissect the complex interaction of KSHV with endothelial cells. This review will outline novel results and pitfalls of these technologies in the elucidation of KSHV pathogenicity.
angiogenesis, interferon, apoptosis, endothelial cells, NF-kappaB
| 1. | ||
Mohammed N. Abid Hussein*, Anita N. Böing*, Augueste Sturk, Chi M. Hau, Rienk Nieuwland Thrombosis and Haemostasis 2007 98 5: 1096-1107 http://dx.doi.org/10.1160/TH05-04-0231 | ||
| 2. | Basic mechanisms and therapeutic advances | |
G. W. Prager (1), M. Poettler (1) Hämostaseologie 2012 32 2: 105-114 http://dx.doi.org/10.5482/ha-1163 | ||
| 3. | ||
A. Bauwens (1), M. Bielaszewska (1), B. Kemper (2), P. Langehanenberg (2), G. von Bally (2), R. Reichelt (3), D. Mulac (4), H.-U. Humpf (4), A. W. Friedrich (1), K. S. Kim (5), H. Karch (1), J. Müthing (1) Thrombosis and Haemostasis 2011 105 3: 515-528 http://dx.doi.org/10.1160/TH10-02-0140 | ||